PHILIPS WKN: 940602 ISIN: NL0000009538 Kürzel: PHIA Forum: Aktien Thema: Hauptdiskussion

Ok. Einer kauft einer verkauft. Kurs bleibt gleich 😂

Tagesvolumen bisher über 3,2 Mio. Durchschnittliches Volumen der letzten 3 Monate war 3,6 Mio. Die Aussage keiner kauft und keiner verkauft trifft also nicht wirklich zu 😉 https://finance.yahoo.com/quote/PHIA.AS

Keiner kauft. Keiner verkauft

Recht hast Du. Durch die Nachkauferei brauch ich 32 , damit es grün wird im Depot. Geduld ist gefragt

Meinst 29€🤔 aber gut gegen 30€ hat hier niemand was

Noch ein klimmzug und die 30 ist wieder da

Nachgelegt

Schnäppchen aber nicht fürs lange

Auch drin… Aktie OS

Bin rein

Royal Philips (PHG -15.3%) ADRs have reached the lowest level since March 2020 after the Dutch health tech firm lowered its sales estimates for 2021. The pre-release indicating nearly EUR 4.9B global sales for the company in Q4 2021, was about EUR 350M lower than the earlier expectations, Philips (NYSE:PHG) said Wednesday. In reaction to the update, Citi analysts led by Kate Kalashnikova have downgraded its stock to Neutral from Buy, noting the worse than expected results, supply chain issues, and potential for more concerns on the company’s decision to recall CPAP respiratory devices. “We do not see a lot of scope for re-rating in the near term,” the analysts added, arguing that the “update further erodes investors’ trust.” The team continues to believe the “significant potential” for the company to enjoy adj. EBITDA margin expansion in the near-term and accelerate revenue due to the robust end-market demand. However, a companywide transformation is required to unlock the potential, the analysts added. The price target lowered to $34.50 from $38.00 per share indicates a downside of ~11.0% to the last close. As of November, Philips (PHG) had set aside EUR 500M as provisions for the recall of millions of ventilators and respiratory devices announced in June.

👀

👀

👀

Die werden aber kommen

Man braucht bessere Quartal Ergebnisse